期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

骨髓增生性疾病所致门静脉海绵样变性1例报告

Cavernous transformation of the portal vein caused by myeloproliferative disease:A case report
下载PDF
导出
摘要 1 病例资料患者男性,64岁,因“乏力1周,黑便3天”于2021年11月22日收入本院。患者于1周前无明显诱因下出现乏力,未重视未就诊,3天前进食辛辣食物后出现中上腹不适,后解黑色糊状便,每天2次,每次约200 mL,头晕乏力较前加重,无畏寒发热,无恶心呕吐,无呕血,无腹痛。患者20年前有胃溃疡伴出血病史,曾行胃镜检查明确,保守治疗后好转,曾因胃溃疡穿孔行修补手术治疗。既往否认慢性病史,否认肝炎、结核、吸烟嗜酒以及特殊服药史。
作者 韩冰 涂传涛 HAN Bing;TU Chuantao(Department of Gastroenterology,Shanghai Fourth People’s hospital,Tongji University School of Medicine,Shanghai 200434,China)
机构地区 同济大学附属上海市第四人民医院消化内科
出处 《临床肝胆病杂志》 CAS 北大核心 2023年第6期1414-1417,共4页 Journal of Clinical Hepatology
基金 国家自然科学基金(81970531) 上海市虹口区卫生健康委员会面上项目(虹卫2002-16)。
关键词 骨髓增殖性疾病 门静脉海绵样变性 食管和胃静脉曲张 Myeloproliferative Disorders Cavernous Transformation of Portal Vein Esophageal and Gastric Varices
分类号 R57 [医药卫生—消化系统]
  • 相关文献

参考文献3

二级参考文献55

  • 1Zai-BoJiang HongShan Xin-YingShen Ming-ShengHuang] Zheng-RanLi Kang-ShunZhu Shou-HaiGuan.Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis[J].World Journal of Gastroenterology,2004,10(13):1881-1884. 被引量：14
  • 2Hasselbalch HC.Chronic inflammation as a promoter of mutagenesis in essential thrombocythemia,polycythemia vera and myelofibrosis.A human inflammation model for cancer development?Leuk Res,2013;37(2):214-220.
  • 3Carlo D,Anna C,Johanna S,et al.TNF-αand IFN-are overexpressed in the bone marrow of Fanconi anemia patients and TNFsuppresses erythropoiesis in vitro.Blood,2003;102(6):2053-2059.
  • 4Danese S,Colombel JF,Peyrin BL,et al.Review article:the role of anti-TNF in the management of ulcerative colitis-past,present and future.Aliment Pharmacol Ther,2013;37(9):855-866.
  • 5Tefferi A,Vardiman JW.Classification and diagnosis of myeloproliferative neoplasms:The 2008 World Health Organization criteria and point-of-care diagnostic algorithms.Leukemia,2008;20(1):14-22.
  • 6Levine RL,Wadleigh M,Cools J,et al.Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis.Cancer Cell,2005;7(4):387-397.
  • 7McClure R,Mai M,Lasho T.Validation of two clinically useful assays for evaluation of JAK2V617F mutation in chronic myeloproliferative disorders.Leukemia,2005;20(1):168-171.
  • 8Park SH,Chi HS,Cho YU,et al.The allele burden of JAK2V617F can aid in differential diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasm.Blood Res,2013;48(2):128-132.
  • 9Alshemmari SH,Rajaan R,Ameen R,et al.JAK2V617F allele burden in patients with myeloproliferative neoplasms.Ann Hematol,2014;93(5):791-796.
  • 10Campbell PJ,Green AR.The myeloproliferative disorders.N Engl J Med,2006;355(23):2452-2466.

共引文献19

临床肝胆病杂志
2023年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部